ALX receptor ligands define a biochemical endotype for severe asthma

Authors

Isabell Ricklefs, Harvard University
Mario Castro, Washington University School of Medicine in St. Louis
Andrea M. Coverstone, Washington University School of Medicine in St. Louis
et al

Journal

JCI Insight

Publication Date

7-20-2017

Volume

2

Issue

14

First Page

e93534

Document Type

Open Access Publication

DOI

10.1172/jci.insight.93534

Rights and Permissions

Ricklefs I, Barkas I, Duvall MG, Cernadas M, Grossman NL, Israel E, Bleecker ER, Castro M, Erzurum SC, Fahy JV, Gaston BM, Denlinger LC, Mauger DT, Wenzel SE, Comhair SA, Coverstone AM, Fajt ML, Hastie AT, Johansson MW, Peters MC, Phillips BR, Levy BD; National Heart Lung and Blood Institute’s Severe Asthma Research Program-3 Investigators. ALX receptor ligands define a biochemical endotype for severe asthma. JCI Insight. 2017 Jul 20;2(14):e93534. doi: 10.1172/jci.insight.93534. Erratum in: JCI Insight. 2018 Mar 22;3(6):

Recommended Citation

Ricklefs, Isabell; Castro, Mario; Coverstone, Andrea M.; and et al, "ALX receptor ligands define a biochemical endotype for severe asthma." JCI Insight. 2, 14. e93534 (2017).
https://digitalcommons.wustl.edu/open_access_pubs/10890